Q4FY23 Result Updates – 19 May 2023

By Team MoneyWorks4MeLast updated May 22, 20234 min read

For education, not investment advice.

Market commentary from . Prices and events are as they stood then.

Weekly Result Updates 19-05-2023

Dear Readers,

Welcome to our weekly company result update note. We understand the importance of staying up-to-date with the latest financial developments of the companies you have invested in. That’s why we are committed to providing you with short and insightful information about the earnings and performance of the companies in our coverage.

In addition to the weekly company result update, after the end of the earnings season, we will also be sending you a quarterly sector result review. This will give you a broader understanding of how these sectors are performing and help you make informed decisions about your investments.

SBI

Q4FY23% Change YoYComments
Advances31,99,26917.0%
Deposits44,23,7779.2%
Net Interest Income (NII)40,392.529.5%NIM at 3.84%
Gross Non-Performing Asset (GNPA)2.78%-118 bps
Profit after tax (PAT)16,694.583.2%

Results were good on account of GNPA improvement.

Check, 10-Year X-ray Now!

Cipla

Q4FY23

YOY(%)

Comment

Revenue Net5,7399.1Domestic formulation sales grew by 3.5% YoY
EBITDA1,17456.6
EBITDA Margin20.5%620
PAT70464.4

Adjusted for COVID, growth was 14% YoY led by momentum across a portfolio of the One-India business. US sales came in at $204mn. International markets grew by 7% YoY, while SAGA reported a 13% decline. API saw a decline of 3% YoY.

At Par Result.

Check, 10-Year X-ray Now!

ITC

Q4FY23YoY(%)Comments
Revenue Net16,1505.5FMCG revenue grew by 19.4% to 4,945 Cr
EBITDA6,20918.9
EBITDA Margin38.45%626bps
PAT508721.4

Good Result on account of increase in revenue and improvement in Margin across all segments.

Check, 10-Year X-ray Now!

Advanced Enzyme

Q4FY23

YOY (%)

Comment

Revenue1395.3The Human Nutrition segment, which contributes ~63% to overall revenue and is even higher in terms of profit, continued to witness weakness on account of recessionary trends in the USA and inventory pile-up at the customers’ end. Ex-Human Nutrition, the portfolio grew by 13% YoY in 4QFY23.
EBITDA449.5
EBITDA Margin31.8%122bps
PAT3227

At Par Result, US business to drive forward margins.

Check, 10-Year X-ray Now!

Amber Enterprises

Q4FY23

YOY (%)

Comment

Revenue300355Led by an uptick in demand for RAC & components coupled with new customer additions.
EBITDA20462.4
EBITDA Margin6.8%31bpsGross margin remained flat YoY mainly due to a change in product mix. However, better operating leverage resulted in an

EBITDA margin improvement

PAT10882.3

Good Result driven by margin improvement.

Check, 10-Year X-ray Now!

Kajaria Ceramics

Q4FY23

YOY (%)

Comment

Revenue ( Consolidated)1,2059
EBITDA1766
EBITDA Margin14.60%-46bpsImprovement in EBITDA margin of 240bps on QOQ basis on account of decline in gas prices and cost optimization initiative.
PAT10813

The decent result on account of easing in input costs.

Check, 10-Year X-ray Now!

Bank of Baroda

Q4FY23% Change YoYComments
Advances9,69,54818.5%International advances grew by 29.9% to 173,988 Cr
Deposits12,03,68815.1%
Net Interest Income (NII)11,52533.8%NIM at 3.53%
Gross Non-Performing Asset (GNPA)3.79%-282 bps
Profit after tax (PAT)4,775168.4%

Results were good, with solid fundamentals on all metrics.

Check, 10-Year X-ray Now!

Bharti Airtel

Q4FY23% Change YoYComments
Revenue36,00914.3%ARPU at 193, Enterprise segment grew by 14.5% to 4,785 Cr, 7.4 Mn 4G subscribers added
EBITDA18,80616.6%EBITDA margin at 52.2%
PAT3,00549.7%

Stable results driven by growth in subscribers & enterprise segment.

Check, 10-Year X-ray Now!

Quess Corp Limited

Rs (Cr)

Q4FY23

YoY(%)

Comment

Revenue ( Consolidated)4,44017Driven by WFM (up 16%), OAM (up 19%), and GTS (up 20%).
EBITDA152-18
EBITDA Margin3.42%-146bpsDue to investments in Product Led Business.
PAT30-61

At Par Result.

Check, 10-Year X-ray Now!

Container Corporation

Q4FY23% Change YoYComments
Revenue2,1846.2%
EBITDA4518.1%EBITDA margin at 20.6%
PAT2797.1%

Subpar results on account of muted EXIM volumes.

Check, 10-Year X-ray Now!

CreditAccess Grameen

Q4FY23% Change YoYComments
Advances21,03126.7%
Net Interest Income (NII)69034.2%NIM at 12.2%
Gross Non-Performing Asset (GNPA)1.21%-170 bps
Profit after tax (PAT)29686%

A solid set of results with improving metrics on all parameters.

Check, 10-Year X-ray Now!

Best Stocks From:

All Weather Alpha Case  Screener Alpha Cases  Business Houses Group


Filed under